128 related articles for article (PubMed ID: 33105146)
1. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis.
Bomholt T; Idorn T; Knop FK; Jørgensen MB; Ranjan AG; Resuli M; Hansen PM; Borg R; Persson F; Feldt-Rasmussen B; Hornum M
Nephron; 2021; 145(1):27-34. PubMed ID: 33105146
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.
Osonoi T; Saito M; Tamasawa A; Ishida H; Tsujino D; Nishimura R; Utsunomiya K
PLoS One; 2014; 9(12):e113468. PubMed ID: 25526642
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
Idorn T; Knop FK; Jørgensen MB; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
Diabetes Care; 2016 Feb; 39(2):206-13. PubMed ID: 26283739
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
Davies MJ; Bain SC; Atkin SL; Rossing P; Scott D; Shamkhalova MS; Bosch-Traberg H; Syrén A; Umpierrez GE
Diabetes Care; 2016 Feb; 39(2):222-30. PubMed ID: 26681713
[TBL] [Abstract][Full Text] [Related]
5. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis.
Hiramatsu T; Ozeki A; Asai K; Saka M; Hobo A; Furuta S
Ther Apher Dial; 2015 Dec; 19(6):598-605. PubMed ID: 26556397
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.
Jung HS; Kim HI; Kim MJ; Yoon JW; Ahn HY; Cho YM; Oh KH; Joo KW; Lee JG; Kim SY; Park KS
Diabetes Technol Ther; 2010 Oct; 12(10):801-7. PubMed ID: 20809681
[TBL] [Abstract][Full Text] [Related]
8. Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Frandsen CS; Dejgaard TF; Holst JJ; Andersen HU; Thorsteinsson B; Madsbad S
Diabetes Care; 2015 Dec; 38(12):2250-7. PubMed ID: 26486191
[TBL] [Abstract][Full Text] [Related]
9. A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
King AB; Philis-Tsimikas A; Kilpatrick ES; Langbakke IH; Begtrup K; Vilsbøll T
Diabetes Technol Ther; 2017 Apr; 19(4):255-264. PubMed ID: 28282219
[TBL] [Abstract][Full Text] [Related]
10. Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes.
Wijkman MO; Dena M; Dahlqvist S; Sofizadeh S; Hirsch I; Tuomilehto J; Mårtensson J; Torffvit O; Imberg H; Saeed A; Lind M
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):105-115. PubMed ID: 30515978
[TBL] [Abstract][Full Text] [Related]
11. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
[TBL] [Abstract][Full Text] [Related]
12. Glucose variability in maintenance hemodialysis patients with type 2 diabetes: Comparison of dialysis and nondialysis days.
Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Jørgensen MB; Feldt-Rasmussen B; Hornum M
Hemodial Int; 2023 Apr; 27(2):126-133. PubMed ID: 36760179
[TBL] [Abstract][Full Text] [Related]
13. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
[TBL] [Abstract][Full Text] [Related]
14. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.
Kazempour-Ardebili S; Lecamwasam VL; Dassanyake T; Frankel AH; Tam FW; Dornhorst A; Frost G; Turner JJ
Diabetes Care; 2009 Jul; 32(7):1137-42. PubMed ID: 19196889
[TBL] [Abstract][Full Text] [Related]
15. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).
Marre M; Shaw J; Brändle M; Bebakar WM; Kamaruddin NA; Strand J; Zdravkovic M; Le Thi TD; Colagiuri S;
Diabet Med; 2009 Mar; 26(3):268-78. PubMed ID: 19317822
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial.
Retnakaran R; Kramer CK; Choi H; Swaminathan B; Zinman B
Diabetes Care; 2014 Dec; 37(12):3270-8. PubMed ID: 25249651
[TBL] [Abstract][Full Text] [Related]
18. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A
Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
